Abstract:Mitochondria are hubs of metabolic activity with a major role in ATP conversion by oxidative phosphorylation (OXPHOS). The mammalian mitochondrial genome encodes 11 mRNAs encoding 13 OXPHOS proteins along with 2 rRNAs and 22 tRNAs, that facilitate their translation on mitoribosomes. Maintaining the internal production of core OXPHOS subunits requires modulation of the mitochondrial capacity to match the cellular requirements and correct insertion of particularly hydrophobic proteins into the inner mitochondrial membrane. The mitochondrial translation system is essential for energy production and defects result in severe, phenotypically diverse diseases, including mitochondrial diseases that typically affect postmitotic tissues with high metabolic demands. Understanding the complex mechanisms that underlie the pathologies of diseases involving impaired mitochondrial translation is key to tailoring specific treatments and effectively targeting the affected organs. Disease mutations have provided a fundamental, yet limited, understanding of mitochondrial protein synthesis, since effective modification of the mitochondrial genome has proven challenging. However, advances in next generation sequencing, cryoelectron microscopy, and multi-omic technologies have revealed unexpected and unusual features of the mitochondrial protein synthesis machinery in the last decade. Genome editing tools have generated unique models that have accelerated our mechanistic understanding of mitochondrial translation and its physiological importance. Here we review the most recent mouse models of disease pathogenesis caused by defects in mitochondrial protein synthesis and discuss their value for preclinical research and therapeutic development.

Mouse Models of Mitochondrial Disease and Their Pathophysiology

Induced Pluripotent Stem Cells: Ex Vivo Models for Human Diseases Due to Mitochondrial DNA Mutations

Patient-specific Induced Pluripotent Stem Cell Models in Mitochondrial Diseases.

Therapeutic and tampering approaches for mitochondrial associated diseases

Nuclear Genes and Mitochondrial Genes Associated with Mitochondrial Diseases

Cell Models and Drug Discovery for Mitochondrial Diseases

Mitochondrial functional defects and the disorders in the nervous system

Pathogenic Mutations of Nuclear Genes Associated with Mitochondrial Disorders.

Advances in Mitochondrial Nucleoid Structure and Related Diseases

Animal Models of Mitochondrial Diseases Associated with Nuclear Gene Mutations

Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization.

Illuminating mitochondrial translation through mouse models

A novel mouse model of mitochondrial disease exhibits juvenile-onset severe neurological impairment due to parvalbumin cell mitochondrial dysfunction

Mitochondrial Dysfunctions: Genetic and Cellular Implications Revealed by Various Model Organisms

Genetically and Metabolically Corrected Pluripotent Stem Cells from Patients with Mtdna Disease

A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator

Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases

A Review over Mitochondrial Diseases Due to mtDNA Mutations: Recent Advances and Remedial Aspects

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases

Mitochondrial diseases and mtDNA editing